Effects of Different Physical Therapy Programs on Pulmonary Rehabilitation in Patients With Lung Cancer
1 other identifier
interventional
90
1 country
1
Brief Summary
This study applies external diaphragm pacemaker and positive expiratory pressure therapy to patients who received thoracic surgeries, in order to explore the effects of different physical therapy programs on pulmonary rehabilitation in patients with lung cancer. As well as we hope that these physical training programs can effectively improve the lung function of patients, reduce postoperative pulmonary complications, hospitalization days, hospitalization expenses, etc.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 30, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedJune 4, 2021
May 1, 2021
1.6 years
December 30, 2020
June 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change from baseline Forced Expiratory Volume In One Second at one month after surgery
Evaluate the change of Forced Expiratory Volume In One Second before the surgery and one month after surgery by conducting Pulmonary Function Test on resectable NSCLC patients
baseline (before the surgery), and one month after surgery
Other Outcomes (2)
The change from baseline Borg Score at one month after surgery.
baseline (before the surgery), and one month after surgery
Complications incidence
One month after surgery
Study Arms (3)
Regular ACBT training
PLACEBO COMPARATORIncluding quitting smoking, ACBT training, cough practicing.
Positive expiratory pressure therapy
EXPERIMENTALUse acpella®PEP therapeutic system and regular nursing care.
External diaphragm pacemaker
EXPERIMENTALPatients are trained to use external diaphragm pacemaker and receive regular nursing care.
Interventions
Performed 5 days before surgery and one month after surgery, twice a day.
Continuously instruct patients to perform positive expiratory pressure training 5 days before surgery and one month after surgery, twice a day.
Use external diaphragm pacemaker to stimulate patients' diaphragms.
Eligibility Criteria
You may qualify if:
- Patients who are diagnosed with non-small cell lung cancer with clear pathological cytology by fiberoptic bronchoscopy and CT, and plan to undergo lobectomy or segmentectomy under general anesthesia for tracheal intubation;
- Age 18-80 years old;
- Those who have stable vital signs and can participate in this research;
- Pulmonary function test FEV1/FVC\>0.8.
- Volunteer to participate in this research and sign an informed consent form.
You may not qualify if:
- Pneumonectomy patients;
- Wedge resection patients
- Patients with distant metastasis of cancer;
- Patients with other malignant tumors;
- Severe complications occurred during the operation, and respiratory function training and testing are not allowed before and after Evaluator;
- Patients with severe physical or mental illness who cannot cooperate with the test;
- Patients with pacemakers, active tuberculosis, and pneumothorax.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat sen University cancer center
Guangzhou, Guangdong, China
Related Publications (1)
Chen X, Li C, Zeng L, Rong T, Lin P, Wang Q, Guo Z, Long H, Zhong J. Comparative efficacy of different combinations of acapella, active cycle of breathing technique, and external diaphragmatic pacing in perioperative patients with lung cancer: a randomised controlled trial. BMC Cancer. 2023 Mar 28;23(1):282. doi: 10.1186/s12885-023-10750-4.
PMID: 36978035DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 30, 2020
First Posted
June 4, 2021
Study Start
May 1, 2020
Primary Completion
November 30, 2021
Study Completion
December 30, 2021
Last Updated
June 4, 2021
Record last verified: 2021-05